Evaluation of evolocumab on saphenous vein graft patency following coronary artery bypass graft surgery in people living with and without diabetes in the NEWTON-CABG CardioLink-5 trial.
- DOI
- 10.1111/dom.70590
- Published
- 2026 May
- Container
- Diabetes, obesity & metabolism
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/dom.70590,
title = {Evaluation of evolocumab on saphenous vein graft patency following coronary artery bypass graft surgery in people living with and without diabetes in the NEWTON-CABG CardioLink-5 trial.},
author = {Teoh H and Verma S and Mancini GBJ and Quan A and Szarek M and Elituv R and Verma M and Misner E and Krishnaraj A and Jüni P and Koren MJ and Nicholls SJ and Bhatt DL and Mazer CD and Leiter LA},
year = {2026},
journal = {Diabetes, obesity \& metabolism},
doi = {10.1111/dom.70590},
url = {https://doi.org/10.1111/dom.70590}
}RIS
TY - JOUR TI - Evaluation of evolocumab on saphenous vein graft patency following coronary artery bypass graft surgery in people living with and without diabetes in the NEWTON-CABG CardioLink-5 trial. AU - Teoh H AU - Verma S AU - Mancini GBJ AU - Quan A AU - Szarek M AU - Elituv R AU - Verma M AU - Misner E AU - Krishnaraj A AU - Jüni P AU - Koren MJ AU - Nicholls SJ AU - Bhatt DL AU - Mazer CD AU - Leiter LA PY - 2026 JO - Diabetes, obesity & metabolism DO - 10.1111/dom.70590 UR - https://doi.org/10.1111/dom.70590 ER -
APA
H, T., S, V., GBJ, M., A, Q., M, S., R, E., M, V., E, M., A, K., P, J., MJ, K., SJ, N., DL, B., CD, M., & LA, L. (2026). Evaluation of evolocumab on saphenous vein graft patency following coronary artery bypass graft surgery in people living with and without diabetes in the NEWTON-CABG CardioLink-5 trial.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.70590
Source records
- pubmed · retrieved 2026-09-26T06:23:25.451Z